Ikarovec Limited
Ikarovec is a pioneering gene therapy company focused on developing innovative treatments for common eye diseases. Their advanced technology aims to restore sight and prevent blindness through targeted gene therapies that offer long-lasting benefits.
Founded: 7 Aug 2018
Industries:
72110 - Research and experimental development on biotechnology
Website: ikarovec.com
Location: Norwich
Products & Services
• biotechnology
• biotechnology
• eye diseases
• gene therapy
• gene therapy for diabetic macular edema
• gene therapy for geographic atrophy
• gene therapy for neovascular age-related macular degeneration
• gene therapy for ocular hypertension
• gene therapy treatments for eye diseases
• health care
• life science
• ocular treatments
Financial Snapshot
Cash in Bank
Turnover
EBITDA
Gross Profit
Total Liabilities
Employees
Unlock financial data with Pro Start Free Trial →
People
Officers
6
Shareholders
13
Controllers (PSC)
4
Peter Oliver Wharton Sexton
Director • British • Lives in United Kingdom • Born in Aug 1973
Parkwalk Advisors Ltd
Corporate Director • United Kingdom
Christopher Michael Baker
Director • British • Lives in England • Born in Jun 1983
Katie Mary Binley
Director • British • Lives in England • Born in Nov 1971
Jean-philippe Combal
Director • French • Lives in France • Born in Aug 1965
Registered Office Address
Innovation Centre Norwich Research Park
Colney Lane, Colney
Norwich
NR4 7GJ
United Kingdom
Basic Information
LTD
7 Aug 2018
ENGLAND WALES
Yes
Industry Classification
72110
Company Attributes
N/A
N/A
N/A
N/A
Summary
13
Officers
4
PSCs
0
Filings